Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways. - Wikidata - awgldk - TriplyDB

Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways.

Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways.

http://www.wikidata.org/entity/Q33504599

about

Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals Antibody responses to envelope glycoproteins in HIV-1 infection The Antibody Response against HIV-1 Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection Virological features associated with the development of broadly neutralizing antibodies to HIV-1 Generation of neutralizing antibodies and divergence of SIVmac239 in cynomolgus macaques following short-term early antiretroviral therapy A novel CCR5 mutation common in sooty mangabeys reveals SIVsmm infection of CCR5-null natural hosts and efficient alternative coreceptor use in vivo HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth Neutralization of tier-2 viruses and epitope profiling of plasma antibodies from human immunodeficiency virus type 1 infected donors from India Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies Autologous neutralizing antibodies to the transmitted/founder viruses emerge late after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes The cat and mouse of HIV-1 antibody escape.Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response.Broadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune System R5 clade C SHIV strains with tier 1 or 2 neutralization sensitivity: tools to dissect env evolution and to develop AIDS vaccines in primate models.Temporal analysis of HIV envelope sequence evolution and antibody escape in a subtype A-infected individual with a broad neutralizing antibody response Rapid escape from preserved cross-reactive neutralizing humoral immunity without loss of viral fitness in HIV-1-infected progressors and long-term nonprogressors The genotype of early-transmitting HIV gp120s promotes α (4) β(7)-reactivity, revealing α (4) β(7) +/CD4+ T cells as key targets in mucosal transmission.Nonpathogenic simian immunodeficiency virus infection of sooty mangabeys is not associated with high levels of autologous neutralizing antibodies.Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individual.Identifying and characterizing recently transmitted viruses.Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections Molecular evolution of HIV-1 CRF01_AE Env in Thai patients Immunization with wild-type or CD4-binding-defective HIV-1 Env trimers reduces viremia equivalently following heterologous challenge with simian-human immunodeficiency virus.Variations in autologous neutralization and CD4 dependence of b12 resistant HIV-1 clade C env clones obtained at different time points from antiretroviral naïve Indian patients with recent infection.Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progression Sequences in glycoprotein gp41, the CD4 binding site, and the V2 domain regulate sensitivity and resistance of HIV-1 to broadly neutralizing antibodies.Human immunodeficiency virus type-1 (HIV-1) continues to evolve in presence of broadly neutralizing antibodies more than ten years after infection.Specificity of the autologous neutralizing antibody response Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120.A versatile vector for the production of pseudotyped viruses expressing gp120 antigens from different clades of primary HIV-1 isolates.Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models.A single amino acid substitution in the C4 region in gp120 confers enhanced neutralization of HIV-1 by modulating CD4 binding sites and V3 loop.The B cell response is redundant and highly focused on V1V2 during early subtype C infection in a Zambian seroconverter.Role of transmitted Gag CTL polymorphisms in defining replicative capacity and early HIV-1 pathogenesis.Prime-boost immunization of rabbits with HIV-1 gp120 elicits potent neutralization activity against a primary viral isolate.

P2860

Q24635002-63734016-6A46-4D1C-A6FA-D81C537E8F0D Q26991572-2FBAA9B5-1AD1-45F7-809C-DCEF808EE830 Q27000889-71D9E051-0F59-4E17-9C2A-BB67C21EA636 Q27022652-A8CE9CB8-66DA-407A-8A06-3A2E0FB6E7A1 Q27025177-A30ACC59-E4FE-48B0-BDD0-3F1697A5A647 Q27313556-30954998-4A16-4BCD-8BB9-6DACCAFC0F84 Q27313759-6CFF77B6-00CE-4645-B3EC-6B0B3CDBEFC4 Q27497560-CE2F71D4-4DA2-4AA1-8C07-6B12A3CB3F7A Q27654848-08B28006-79E2-4BF2-B183-F3A46F4FB8FF Q27676728-6132BA0B-BA91-43ED-BF17-1B5E81C852E0 Q28483205-80401205-EC05-4B4A-B6A9-CECEA11B2ABF Q28602877-BB7D814B-18DF-4141-9387-E9F5F6B1EFA3 Q28751926-9F7436EB-722D-40F0-95B7-624362187F7A Q28752503-77C303CE-9301-44C0-907A-A40773A1512E Q33504607-F1A8C767-45CB-46A1-AF7C-B70CF896CFE5 Q33591409-D260BA34-A68D-4936-92D9-E41FBF193411 Q33592852-234BEBFD-046A-42A2-A466-65C77544A255 Q33640144-1940318A-5D92-49C2-BAD1-F7CC09AF97C3 Q33664910-56569FE8-79A8-4EF3-A0FB-C09193FC144B Q33725673-34B7B5BD-0B5C-4525-A2C2-310BE18D2753 Q33839456-62CAAFCB-F001-405A-83FF-2FBDC7A1AD23 Q33877434-8946C528-0BE1-40BC-A00F-DA0A88386D91 Q33912373-BA0AD09B-61E7-40EE-B59D-183706D004B6 Q34038460-3D41903A-E091-4226-B4C3-D6CF19FAF753 Q34042642-7E8FCF5E-9F10-4932-BD4D-DC7015BB4979 Q34071790-A006237A-26D0-4042-B38A-752F75F57FCB Q34120088-707FFBD1-9783-43BB-B466-301BEE86E4C1 Q34203163-A31B5561-B7CA-49D4-B657-628358B6509F Q34300812-417193E9-3A1E-4457-A0CB-F915969F884F Q34350944-285EAAF4-2E6D-44F9-9AE5-A8BBDE1D023C Q34397758-F3B71542-1D66-48C1-9AE3-087402AB7669 Q34407843-52CF7251-11F9-46D8-90B7-8E3C920177EF Q34415389-6E41D1F0-687D-444C-92AD-E0788537E7FC Q34428738-A98517AD-3F87-4F08-9123-4C862D6707BD Q34444535-E08E4C20-25A7-4E19-9464-5F48BE18A3CC Q34455457-2469B62D-86AB-4B4B-8834-7B4491E75AC2 Q34463861-C83EB1D5-4B5A-4633-8703-56A6F29D692A Q34485260-F99EC93A-333D-44CF-99B1-D3FC2B4948A0 Q34499377-29BDCF14-FA06-4D75-B794-B107CEAE9432 Q34551010-7979D1A2-336F-4F51-B273-938550957385

P2860

Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways.

http://www.wikidata.org/entity/Q33504599

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Escape from autologous neutral ...... on requires multiple pathways.

@ast

Escape from autologous neutral ...... on requires multiple pathways.

@en

type

label

Escape from autologous neutral ...... on requires multiple pathways.

@ast

Escape from autologous neutral ...... on requires multiple pathways.

@en

prefLabel

Escape from autologous neutral ...... on requires multiple pathways.

@ast

Escape from autologous neutral ...... on requires multiple pathways.

@en

P1433

Q33504599-3C883BD2-1F07-45C7-886A-C1FDA6851758

P1476

Q33504599-35F450A6-44FC-4342-A21F-CC17F9FD7E60

P2093

Q33504599-483F591A-6172-4357-A8DE-039456A33C41

Q33504599-5D182091-A0DF-472C-A099-12422084DF45

Q33504599-5E843DA9-776D-484D-AF3B-2BD7259FAE5C

Q33504599-65A01499-4A54-40BC-9117-BB1B87E060F2

Q33504599-80C50B0B-D929-46D9-9FE4-A3E0FD47379C

Q33504599-85D32443-4592-43C6-AC7B-BAC322742314

Q33504599-9D6C7C77-315A-4FFD-87E6-338E37E4B55D

Q33504599-A35CF281-7AD8-490B-805A-20BD0D78183F

Q33504599-A4024F8C-3E1F-41CC-93FB-1E9D9697D553

Q33504599-DBA3A286-D2CB-436C-A068-FC73786046D0

P2860

Q33504599-02EAC5D5-3424-49AD-BD2C-6E816F5D80F6

Q33504599-0ABD8766-0F3B-4821-95C8-432853942215

Q33504599-0D469EF6-5E1A-4D8A-BDBD-261A17CFCED5

Q33504599-0FFF436D-DEDE-498B-ABD5-8F542B85CC10

Q33504599-14916AA3-6BD1-4D90-B8A9-43BB01302AAA

Q33504599-1813D893-CF8D-4D2E-A0B3-0A3CC1EA6B74

Q33504599-1FBDCC55-C456-44C5-9776-5969BC000B0B

Q33504599-23794EDA-75EA-4BD7-A919-E26D78710F90

Q33504599-250E953C-3AB3-4C28-874D-903FC5AAE89C

Q33504599-25AB45FE-3BBB-4A79-BFBC-3C073FE0FA25

P304

Q33504599-264ACC9E-43CD-4B7E-A06B-88E12F270100

P31

Q33504599-EA2E3109-1C58-4669-B962-072D93BAAE4E

P356

Q33504599-8049D6E4-1F22-4503-95C0-D29E9F1B9B23

P433

Q33504599-C2D59C77-6174-4F44-B4D0-3E4373C68479

P478

Q33504599-A75BA954-E5E3-4A3F-9314-BC6351728EC0

P50

Q33504599-0ABEC9FB-1CAE-49BE-B5B6-C21AA58E83F3

Q33504599-557F0060-70D7-447A-B5DC-23F6743FDD17

P577

Q33504599-5AD04571-0768-42D7-9A73-94165D4C0362

P5875

Q33504599-44A65F90-34B1-41B9-A209-3FEDBFF55C96

P698

Q33504599-9FB7A271-52B7-4817-A647-B780CF87D27D

P921

Q33504599-82BBD5BA-5536-4341-AFC5-B86C657DA7FB

P932

Q33504599-EE3834C8-4B34-4866-A246-9C43B2947DAC

P356

JOURNAL.PPAT.1000594

P1433

P1476

Escape from autologous neutral ...... on requires multiple pathways.

@en

P2093

Abraham Pinter

http://www.w3.org/2001/XMLSchema#string

Bing Li

http://www.w3.org/2001/XMLSchema#string

Cynthia A Derdeyn

http://www.w3.org/2001/XMLSchema#string

Eric Hunter

http://www.w3.org/2001/XMLSchema#string

James E Robinson

http://www.w3.org/2001/XMLSchema#string

Joseph Mulenga

http://www.w3.org/2001/XMLSchema#string

Megan K Murphy

http://www.w3.org/2001/XMLSchema#string

Rebecca M Lynch

http://www.w3.org/2001/XMLSchema#string

Richard E Haaland

http://www.w3.org/2001/XMLSchema#string

Rong Rong

http://www.w3.org/2001/XMLSchema#string

P2860

Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection

Structural definition of a conserved neutralization epitope on HIV-1 gp120

Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates

Molecular architecture of native HIV-1 gp120 trimers

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza

Antibody neutralization and escape by HIV-1

Structure of an unliganded simian immunodeficiency virus gp120 core

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

P304

e1000594

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1000594

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26820841

http://www.w3.org/2001/XMLSchema#string

P698

19763269

http://www.w3.org/2001/XMLSchema#string

P921

P932

2741593

http://www.w3.org/2001/XMLSchema#string